Type | Public | |
Founded | 1991 | |
HQ | Salt Lake City, UT, US | Map |
Website | myriad.com | |
Employee Ratings | More | |
Overall Culture | B- | More |
USD | |
---|---|
Revenue (FY, 2020) | 638.6m |
Net income (FY, 2020) | (199.6m) |
EBIT (FY, 2020) | (231.7m) |
Market capitalization (8-Feb-2021) | 2.3b |
Closing stock price (8-Feb-2021) | 30.4 |
Cash (30-Jun-2020) | 163.7m |
EV | 2.4b |
USD | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 |
---|---|---|---|---|---|---|---|---|---|
Cash | 87.9m | 88.7m | 97.4m | 93.3m | 90.6m | 84.9m | 89.9m | 81.2m | |
Accounts Receivable | 113.2m | 121.1m | 123.7m | 119.1m | 116.6m | 142.6m | 4.8m | 118.3m | 102.5m |
Prepaid Expenses | 9.5m | 9.8m | 10.1m | 11.5m | 12.5m | 11.3m | 14.0m | 16.2m | |
Inventories | 38.9m | 38.2m | 33.4m | 35.9m | 33.3m | 31.9m | 28.1m | 28.1m | 30.8m |
USD | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 |
---|---|---|---|---|---|---|---|---|---|
Net Income | 81.1m | 113.2m | 124.6m | (700.0k) | 1.9m | 8.8m | (20.6m) | (28.9m) | (144.1m) |
Depreciation and Amortization | 13.2m | 26.3m | 39.3m | 18.3m | 36.3m | 54.6m | 18.2m | 36.4m | 54.3m |
Inventories | 3.3m | 4.1m | 8.9m | 3.5m | 6.1m | 7.4m | 3.1m | 2.6m | |
Accounts Payable | 400.0k | 3.0m | (2.0m) | (8.4m) | (300.0k) | (8.1m) | (9.3m) | (11.3m) | (2.1m) |
USD | FY, 2017 |
---|---|
Revenue/Employee | 321.4k |
Debt/Equity | 0.3 x |
Debt/Assets | 0.2 x |
Financial Leverage | 1.6 x |
Company Name | Date | Deal Size |
---|---|---|
Myriad Women’s Health | May 29, 2018 | $408.60 m |
Myriad Neuroscience | August 03, 2016 | $351.60 m |
Sividon Diagnostics | May 31, 2016 | $56 m |
Privatklinik Dr. Robert Schindlbeck | February 27, 2015 | $20.10 m |
Crescendo Bioscience | February 04, 2014 | $270 m |
Rules-Based Medicine | April 27, 2011 | $80 m |
Javelin Pharmaceuticals | December 18, 2009 | $95 m |
NaturNorth Technologies | April 10, 2008 | |
AssureRx Canada, Ltd | ||
Assurex Health, Inc. |
Myriad Genetics revenue breakdown by business segment: 7.2% from Pharmaceutical and Clinical Services and 92.8% from Molecular Diagnostic Testing
Myriad Genetics has 6.2k Twitter Followers. The number of followers has increased 0.3% month over month and increased 1.4% quarter over quarter
17.2k
Tweets
858
Following
6.2k
Followers
16
Tweets last 30 days
1.1
Avg. likes per Tweet
81.3%
Tweets with engagement
B-
70/100
D
61/100
B
74/100
When was Myriad Genetics founded?
Myriad Genetics was founded in 1991.
Who are Myriad Genetics key executives?
Myriad Genetics's key executives are Bryan Riggsbee, Paul J. Diaz and Patrick Burke.
How many employees does Myriad Genetics have?
Myriad Genetics has 2,600 employees.
What is Myriad Genetics revenue?
Latest Myriad Genetics annual revenue is $638.6 m.
What is Myriad Genetics revenue per employee?
Latest Myriad Genetics revenue per employee is $245.6 k.
Who are Myriad Genetics competitors?
Competitors of Myriad Genetics include Progenity, Foundation Medicine and Genomic Health.
Where is Myriad Genetics headquarters?
Myriad Genetics headquarters is located at 320 Wakara Way, Salt Lake City.
Where are Myriad Genetics offices?
Myriad Genetics has offices in Salt Lake City, Austin, South San Francisco, Issy-les-Moulineaux and in 8 other locations.
How many offices does Myriad Genetics have?
Myriad Genetics has 13 offices.
Receive alerts for 300+ data fields across thousands of companies